What does a Wegovy weight-loss journey actually look like?

What happens in the first few weeks on Wegovy?

The opening weeks are often quieter than people expect. You start at 0.25 mg, a dose that exists entirely to let your digestive system adapt, not to produce dramatic weight loss. Most people notice some nausea after the first injection, sometimes a dip in appetite, occasionally a little fatigue. These are the most commonly reported effects early in treatment, and for many they soften considerably within ten days or so. Some people feel almost nothing.

What matters most at this stage is consistency: the same day each week, same general routine. Your prescriber and the patient information leaflet are the right guides for any questions about what you're experiencing, not online forums, which tend to over-represent the harder stories. The first month's job is adjustment. That's it.

The week-by-week pattern of semaglutide treatment is worth reading alongside this, because it maps the early timeline in granular detail, including when most people begin to notice appetite changes becoming more consistent.

How does the dose increase phase of a Wegovy journey work?

After roughly four weeks at 0.25 mg, the schedule moves to 0.5 mg, then 1.0 mg, then 1.7 mg, before arriving at the standard 2.4 mg maintenance dose. The MHRA has also approved a higher 7.2 mg dose for eligible adults, initially available across multiple pens and more recently as a dedicated single-dose pen, though availability at any given dose is always confirmed at clinical review, not assumed. The titration is designed this way because higher doses carry a higher likelihood of GI side effects; climbing the ladder slowly reduces that risk meaningfully.

Not everyone reaches 2.4 mg at the same pace. A prescriber may recommend staying at a lower dose for longer if side effects are significant, or if progress is already satisfactory. That's a clinical judgment, not a failure. Some people's Wegovy journey finds its equilibrium at 1.7 mg; others move all the way to 7.2 mg. The full Wegovy treatment overview covers how these decisions are made in practice.

The STEP 1 trial, published in the New England Journal of Medicine, followed adults on 2.4 mg semaglutide for 68 weeks alongside lifestyle changes and recorded an average weight reduction of around 15%, a figure that gives a realistic reference point, not a promise of what any individual will achieve.

What changes during the maintenance phase, and how long does treatment last?

Once you reach your maintenance dose, the rhythm becomes quieter. A weekly injection, a monthly clinical review, and the gradual accumulation of change. Many people find the appetite shift feels most reliable at this point: meals feel satisfying with less food, and the impulse to eat between them dulls. Tracking your Wegovy weight-loss journey through a simple log can help you spot patterns and give your prescriber useful information at each review.

NICE guidance on semaglutide notes that NHS use is recommended for a maximum of two years within specialist services, though private treatment pathways differ and duration is always a clinical decision. The Wegovy journal guide has practical suggestions for recording your progress in a way that's actually useful rather than just another obligation. Understanding whether the results are meeting your goals is part of what evaluating whether Wegovy is worth the cost looks like in practice.

Side effects at maintenance are often much reduced compared with the titration phase, though GI symptoms can return after a dose increase. If you want a broader grounding in how the active ingredient works, our guide to semaglutide explains the mechanism and what to expect at each stage of treatment. The NHS semaglutide medicine page lists symptoms that warrant prompt medical attention, including severe and persistent stomach pain, signs of an allergic reaction, or any sudden changes in vision. These are uncommon, but knowing what to watch for is part of any sensible treatment plan. Patients can also report unexpected side effects directly through the MHRA's Yellow Card scheme.

What does coming off Wegovy look like, and what stays with you?

This is a question our prescribers hear regularly, and it deserves a straight answer. When semaglutide is stopped, appetite typically returns toward its previous baseline over weeks to months. The hormonal signals that the medicine was amplifying fade. That doesn't mean the journey ends without lasting benefit, many people build genuinely different habits during treatment, and those habits don't vanish with the final injection. People also sometimes ask whether semaglutide works as a fat burner, and the answer is more nuanced than the phrase suggests, touching on how the medicine influences appetite and metabolism rather than directly targeting fat stores. But relying on the medicine alone to permanently restructure appetite without parallel lifestyle work makes the transition harder.

Planning for the end of treatment is a conversation worth starting well before the last dose. It belongs in the same clinical review where you'd discuss anything else about your progress. If you're considering starting your Wegovy journey, or you're already partway through and want clinical support from a registered prescriber, you can speak to our prescribers through a free consultation. The pen that arrives (tracked by DPD, in plain unbranded packaging) is the visible part of a longer process that includes that ongoing clinical relationship at every step.